Pelvic lymphangioma is a rare, benign tumor originating from the lymphatic system, characterized by the abnormal formation and dilation of lymphatic vessels.
These tumors are typically found in the pelvic region and can vary in size from small, asymptomatic lesions to large masses that may cause discomfort or pain due to pressure on adjacent structures.
Lymphangiomas are congenital malformations that result from the sequestration of lymphatic tissue during embryonic development.
Though benign, their ability to grow and exert pressure on surrounding organs can lead to complications such as obstruction of the urinary tract or bowel, depending on their size and exact location within the pelvis.
Diagnosis of pelvic lymphangioma typically involves imaging studies, where scans like ultrasound, CT, or MRI can be utilized to visualize the extent and impact of the tumor on surrounding tissues.
Treatment options may include surgical excision, particularly for symptomatic cases, or sclerotherapy, which involves injecting a substance into the lymphangioma to shrink it.
The condition is more prevalent in children but can also appear in adults.
Early diagnosis and management are important to prevent potential complications and ensure optimal outcomes.
Despite their benign nature, careful monitoring is essential to address any changes in size or symptoms promptly.